Delivery Order SPE2DB22D2214-SPE2DB25FS3FC

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,773.96 Firm Fixed Price Delivery Order contract is for the supply of 4,565,366 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024. The $10,253.36 firm fixed-price delivery order is for the supply of 4,565,427,771 units of Pantoprazole Sodium Delayed-Release 20 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.21 firm fixed-price delivery order is for the supply of pantoprazole sodium delayed-release 20 mg tablets in 90-count packages. The contract has an ultimate completion date of July 29, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $739.20 firm fixed price delivery order by the Defense Logistics Agency to supply 1,000 tablets of the 40mg pantoprazole sodium delayed release medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8-11, 2023. The delivery order was issued under the DLA's Prime Vendor program, which establishes...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Omeprazole delayed-release capsules. The contract has a ceiling value of $23,590.38 and a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,262.62 firm fixed-price delivery order is for the supply of 1,000 units of 40 mg Omeprazole delayed-release capsules. The contract has a period of performance through May 6, 2024 and was awarded on May 3, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.15 firm fixed-price delivery order contract is for the supply of First-Omeprazole 2 mg/ml suspension, with a period of performance through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $13,515.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of "TABLOID 40 MG TABLET 25S", a medical product, with a period of performance through December 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,672.78 for the supply of 4,559,814,411 units of lansoprazole ODT 15 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 2, 2023, with a completion date of February 3, 2023. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS3FC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,688.38 for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of January 3, 2025 and is a Firm Fixed Price arrangement.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/3/25, 10:13 AM